CRISPR is a groundbreaking gene-editing tool that allows scientists to make highly specific changes to DNA. The system was originally discovered as a bacterial defense mechanism against viruses, where bacteria store fragments of viral DNA in special regions of their genome called CRISPR sequences. These fragments are used to create guide RNAs (gRNAs) that pair with a DNA-cutting enzyme called Cas9. When the same virus tries to attack again, the guide RNA matches with the viral DNA, and Cas9 cuts it, disabling the virus.
Scientists realized that this natural system could be repurposed in the lab to edit any gene by designing a custom guide RNA that leads Cas9 toa specific DNA sequence. Once the Cas9 enzyme cuts the DNA, the cell tries to repair the break. This repair process can introduce mutations that deactivate the gene, or scientists can insert a new piece of DNA to replace the original sequence. This makes CRISPR much faster, cheaper, and more precise than earlier gene-editing technologies like ZFNs and TALENs.
CRISPR is transforming cancer research by allowing scientists to study the function of individual genes involved in cancer. By using CRISPR to “knock out” or edit specific genes in cancer cells, researchers can see which genes are essential for tumor growth, metastasis, and drug resistance. For example, in the Cancer Dependency Map project, scientists used CRISPR to disable thousands of genes across hundreds of cancer cell lines. They identified over 600 genes that tumors depend on for survival—potential new targets for cancer drugs.
CRISPR is also used to create precise cancer models in cell cultures and animals by introducing mutations in oncogenes (genes that cause cancer when mutated) or disabling tumor suppressor genes (which normally prevent cancer). These models help researchers study how tumors develop and test potential treatments in a more controlled and accurate way.
In cancer treatment, CRISPR is being used experimentally to engineer patients’ immune cells to fight cancer more effectively. For instance, in clinical trials, scientists use CRISPR to modify T cells so they can better recognize and attack cancer cells. This includes deleting genes that suppress T cell function and inserting new genes that help them target tumor-specific antigens. One study modified T cells to recognize a protein called WT1, which is found in many tumors. These edited cells were then infused back into patients, showing early signs of safety and effectiveness.
This connects directly to what we learned in AP Biology, especially in our molecular genetics unit. We studied how DNA is transcribed into RNA and translated into proteins, and how mutations can affect gene expression. CRISPR works by directly targeting DNA to create those mutations or introduce new sequences, changing how genes are expressed. We also learned about bacterial immune responses and plasmid-based gene transfer—CRISPR was originally discovered as a prokaryotic immune system that captures viral DNA, and that same system is now one of the most powerful tools in modern medicine.
This topic is especially exciting to me because I want to go into cancer research and oncology. It’s incredible to see how a molecular system that bacteria use to fight viruses is now being used to fight cancer in humans. CRISPR allows researchers to explore the genetic roots of cancer and develop therapies that are personalized, precise, and potentially curative. Learning about how CRISPR works not just in theory but in actual clinical settings motivates me to be part of the next wave of scientists and doctors using genetics to save lives.
Leave a Reply